These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 8562158)
1. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients. Viscoli C; Bruzzi P; Glauser M Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158 [TBL] [Abstract][Full Text] [Related]
2. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients. Paul M; Borok S; Fraser A; Vidal L; Cohen M; Leibovici L Cochrane Database Syst Rev; 2005 Jul; (3):CD003914. PubMed ID: 16034915 [TBL] [Abstract][Full Text] [Related]
3. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074 [TBL] [Abstract][Full Text] [Related]
4. The evolution of the empirical management of fever and neutropenia in cancer patients. Viscoli C J Antimicrob Chemother; 1998 Jun; 41 Suppl D():65-80. PubMed ID: 9688453 [TBL] [Abstract][Full Text] [Related]
5. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials. Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227 [TBL] [Abstract][Full Text] [Related]
6. Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer. Paul M; Dickstein Y; Borok S; Vidal L; Leibovici L Cochrane Database Syst Rev; 2014 Jan; (1):CD003914. PubMed ID: 24425445 [TBL] [Abstract][Full Text] [Related]
7. Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute. Pizzo PA J Hosp Infect; 1990 Apr; 15 Suppl A():41-8. PubMed ID: 1971644 [TBL] [Abstract][Full Text] [Related]
8. Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Phillips B; Selwood K; Lane SM; Skinner R; Gibson F; Chisholm JC; Arch Dis Child; 2007 Jun; 92(6):495-8. PubMed ID: 17284481 [TBL] [Abstract][Full Text] [Related]
9. Empirical antibiotics for febrile neutropenic cancer patients. Hathorn JW Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109 [TBL] [Abstract][Full Text] [Related]
10. Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement? Feld R Support Care Cancer; 1998 Sep; 6(5):444-8. PubMed ID: 9773461 [TBL] [Abstract][Full Text] [Related]
11. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091 [TBL] [Abstract][Full Text] [Related]
12. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia]. Jarque I; Sanz MA Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194 [TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial. Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962 [TBL] [Abstract][Full Text] [Related]
14. Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis. Goldberg E; Gafter-Gvili A; Robenshtok E; Leibovici L; Paul M Eur J Cancer; 2008 Oct; 44(15):2192-203. PubMed ID: 18706808 [TBL] [Abstract][Full Text] [Related]
15. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Furno P; Bucaneve G; Del Favero A Lancet Infect Dis; 2002 Apr; 2(4):231-42. PubMed ID: 11937423 [TBL] [Abstract][Full Text] [Related]
17. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359 [TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis. Furno P; Dionisi MS; Bucaneve G; Menichetti F; Del Favero A Support Care Cancer; 2000 Jul; 8(4):293-301. PubMed ID: 10923769 [TBL] [Abstract][Full Text] [Related]
19. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis. Shenep JL NCI Monogr; 1990; (9):117-22. PubMed ID: 2342588 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration. Hughes WT; Pizzo PA; Wade JC; Armstrong D; Webb CD; Young LS Clin Infect Dis; 1992 Nov; 15 Suppl 1():S206-15. PubMed ID: 1477232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]